Stableford Capital II’s Amgen AMGN Stock Holding History

Stableford Capital II’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,993	Closed	-$343K	–	112
2017 Q2	$343K	Buy	1,993 +101	+5%	+$16.4K	0.27%	75
2017 Q1	$310K	Buy	+1,892	New	+$314K	0.27%	74

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stableford Capital II's AMGN Position: Q3 2017 in Review

Stableford Capital II sold out of Amgen (AMGN) in Q3 2017, closing a stake of 1,993 shares — an estimated $343K sold.

Stableford Capital II first reported a position in AMGN in Q1 2017 and held it in 2 quarters. The position peaked at $343K in Q2 2017. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

Stableford Capital II reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
Stableford Capital II sold 1,993 Amgen shares in Q3 2017, an estimated $343K.
Stableford Capital II first reported a position in Amgen in Q1 2017 and held it in 2 quarters.
Stableford Capital II's Amgen position peaked at $343K in Q2 2017.
1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Stableford Capital II's 13F filing for Q3 2017, filed 10 Feb 2021.